Related Experiment Videos
Current Standard and Future Perspectives in the Treatment of Gastrointestinal Stromal Tumors
Silke Cameron1, Alexander Beham, Hans-Ulrich Schildhaus
1Clinic for Gastroenterology and Gastrointestinal Oncology, University Medicine, Göttingen, Germany.
Abstract:
The origin of gastrointestinal stromal tumors (GIST) from interstitial cells of Cajal or their precursor cells has been understood since the early 1990s. The first mutations within the KIT-gene have been described in the late 1990s. Even though these mutations were the breakthrough of small molecular therapy, we still do not know the factors responsible for their malignant transformation. Until then, we can only speak of recurrence risk. This review gives an introduction on the current understanding of GIST and highlights the remaining questions for diagnosis, tumor progression, and treatment in progressive disease.
Insights
Gastrointestinal stromal tumors (GIST) originate from interstitial cells of Cajal. While KIT-gene mutations enabled targeted therapies, the causes of malignant transformation and recurrence risk factors remain unclear.
Area of Science:
- Gastroenterology
- Oncology
- Molecular Biology
Background:
- Gastrointestinal stromal tumors (GIST) are understood to originate from interstitial cells of Cajal or their precursors since the early 1990s.
- KIT-gene mutations, identified in the late 1990s, were pivotal for developing small molecular therapies for GIST.
Purpose of the Study:
- To provide an overview of the current understanding of GIST.
- To highlight unresolved questions in GIST diagnosis, tumor progression, and treatment strategies for advanced disease.
Main Methods:
- Literature review of GIST pathogenesis, diagnosis, and treatment.
- Analysis of current knowledge gaps and future research directions.
Main Results:
- The cellular origin and key genetic mutations (KIT-gene) in GIST are established.
- Factors driving malignant transformation and precise recurrence risk assessment remain largely unknown.
Conclusions:
- Despite therapeutic advances, the etiology of GIST malignant transformation requires further investigation.
- Addressing knowledge gaps in diagnosis and progression is crucial for optimizing treatment in advanced GIST.